Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tumor promoting agent induces lymphocyte mitogenic factor

S K Sundar, D V Ablashi, P H Levine

    Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]
    |March 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    KIR2DL4-HLAG interaction at human NK cell-oligodendrocyte interfaces regulates IFN-γ-mediated effects.

    Molecular immunology·2018
    Same author

    Is the etiology of eosinophilic esophagitis in adults a response to allergy or reflux injury? Study of cellular proliferation markers.

    Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2009
    Same author

    Reciprocal relationship between expression of hypoxia inducible factor 1alpha (HIF-1alpha) and the pro-apoptotic protein bid in ex vivo colorectal cancer.

    British journal of cancer·2008
    Same author

    Intra-operative pathological diagnosis of chronic ulcerative colitis in the two stage ileal pouch anal anastomosis.

    Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland·2007
    Same author

    Malignant transformation of a recurrent vestibular schwannoma.

    Journal of clinical pathology·2003
    Same author

    Multicenter comparison of serologic assays and estimation of human herpesvirus 8 seroprevalence among US blood donors.

    Transfusion·2003
    Same journal

    Characterization of a major natural killer activity in rat lungs.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Decreased phagocytosis and antibody-dependent cellular cytotoxicity (ADCC) in type-1 diabetes.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    [Alveolar macrophages in asthmatic patients: study of their phagocytic function].

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Effect of salbutamol, a putative cerebral beta agonist on sleep stages and interictal epileptic discharges.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Ganglioside content and pattern in tumor tissue of human neuroblastomas.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    Same journal

    Protective effect of levamisole on carbon tetrachloride-induced lipid peroxidation and hepatotoxicity.

    Biomedicine / [publiee pour l'A.A.I.C.I.G.]·1981
    See all related articles

    Human peripheral blood cells treated with 12-O-tetradecanoyl phorbol 13-acetate (TPA) released a lymphocyte mitogenic factor (MF). This protein stimulated normal lymphocyte proliferation within 40-46 hours.

    Area of Science:

    • Immunology
    • Cell Biology

    Background:

    • Tumor-promoting agents can modulate immune cell activity.
    • Understanding immune responses to chemical stimuli is crucial in cancer research.

    Purpose of the Study:

    • To investigate the release and function of soluble factors from human peripheral mononuclear cells stimulated by a tumor promoter.
    • To characterize the mitogenic activity of a novel factor induced by 12-O-tetradecanoyl phorbol 13-acetate (TPA).

    Main Methods:

    • Human peripheral mononuclear cells were treated with TPA.
    • Culture supernatant was collected at various time points.
    • The mitogenic potential of the supernatant on normal human lymphocytes was assessed via proliferation assays.

    Main Results:

    Related Experiment Videos

    • TPA treatment induced the release of a soluble lymphocyte mitogenic factor (MF).
    • MF elicited a significant proliferative response in normal human lymphocytes within 40-46 hours.
    • MF was detectable in culture supernatant from 12 hours post-TPA treatment, peaking at 48 hours.

    Conclusions:

    • TPA induces the release of a potent lymphocyte mitogenic protein from human peripheral mononuclear cells.
    • This MF plays a role in modulating lymphocyte activity in response to tumor-promoting agents.
    • Further biochemical characterization of MF is warranted to elucidate its precise mechanism of action.